Pacer Advisors Inc. Purchases New Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Pacer Advisors Inc. acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) in the 4th quarter, Holdings Channel.com reports. The firm acquired 1,272 shares of the company’s stock, valued at approximately $113,000.

A number of other institutional investors also recently made changes to their positions in USPH. BNP Paribas Financial Markets lifted its position in shares of U.S. Physical Therapy by 283.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock valued at $1,425,000 after acquiring an additional 12,445 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after purchasing an additional 956 shares in the last quarter. State Street Corp lifted its position in U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after purchasing an additional 99,244 shares during the period. Stifel Financial Corp grew its stake in U.S. Physical Therapy by 12.1% during the third quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock worth $4,838,000 after buying an additional 6,154 shares in the last quarter. Finally, Harbor Capital Advisors Inc. increased its holdings in U.S. Physical Therapy by 113.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 16,188 shares of the company’s stock valued at $1,370,000 after buying an additional 8,604 shares during the period.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at $1,970,141.25. This trade represents a 2.46 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the transaction, the chief operating officer now directly owns 7,106 shares in the company, valued at approximately $684,236.74. This represents a 19.52 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,412 shares of company stock valued at $706,605. 1.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. JMP Securities started coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price on the stock. JPMorgan Chase & Co. increased their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Finally, Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price target for the company from $100.00 to $115.00 in a report on Monday, December 16th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $114.00.

U.S. Physical Therapy Stock Up 0.6 %

USPH stock opened at $88.70 on Wednesday. The stock’s 50 day simple moving average is $91.65 and its 200 day simple moving average is $88.52. The company has a market cap of $1.34 billion, a P/E ratio of 94.36, a price-to-earnings-growth ratio of 3.65 and a beta of 1.48. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.